Development of 18F-labeled picolinamide probes for PET imaging of malignant melanoma

Journal of Medicinal Chemistry

Volumn 56, Issue 3, 2013, Pages 895-901

  Liu, Hongguang ^a   Liu, Shuanglong ^a   Miao, Zheng ^a   Deng, Zixin ^b   Shen, Baozhong ^c   Hong, Xuechuan ^b   Cheng, Zhen ^a  

^a STANFORD UNIVERSITY   (United States)

^b WUHAN UNIVERSITY   (China)

^c HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; N [2 (DIETHYLAMINO)ETHYL] 4 FLUOROPICOLINAMIDE FLUORODEOXYGLUCOSE F 18; N [2 (DIETHYLAMINO)ETHYL] 5 FLUOROPICOLINAMIDE FLUORODEOXYGLUCOSE F 18; N [2 (DIETHYLAMINO)ETHYL] 6 FLUOROPICOLINAMIDE FLUORODEOXYGLUCOSE F 18; PICOLINAMIDE; UNCLASSIFIED DRUG; AMIDE; DIAGNOSTIC AGENT; FLUORINE; PICOLINIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG SCREENING; DRUG STABILITY; DRUG UPTAKE; EARLY DIAGNOSIS; FLUORINATION; ISOTOPE LABELING; MELANOMA; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; ANIMAL; C57BL MOUSE; EXPERIMENTAL MELANOMA; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SCINTISCANNING;

AMIDES; ANIMALS; EARLY DIAGNOSIS; FLUORINE RADIOISOTOPES; MAGNETIC RESONANCE SPECTROSCOPY; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; PICOLINIC ACIDS; POSITRON-EMISSION TOMOGRAPHY;

MLCS; MLOWN;

EID: 84873895896     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm301740k     Document Type: Article

References (31)

1. Jemal, A.; Siegel, R.; Ward, E.; Murray, T.; Xu, J.; Thun, M. J. Cancer statistics, 2007 CA-Cancer J Clin. 2007, 57, 43-66
2. Jemal, A.; Siegel, R.; Xu, J.; Ward, E. Cancer statistics, 2010 CA-Cancer J Clin. 2010, 60, 277-300
3. Belhocine, T. Z.; Scott, A. M.; Even-Sapir, E.; Urbain, J. L.; Essner, R. Role of nuclear medicine in the management of cutaneous malignant melanoma J. Nucl. Med. 2006, 47, 957-967
4. Prichard, R. S.; Hill, A. D.; Skehan, S. J.; O'Higgins, N. J. Positron emission tomography for staging and management of malignant melanoma Br. J. Surg. 2002, 89, 389-396
5. Massoud, T. F.; Gambhir, S. S. Molecular imaging in living subjects: Seeing fundamental biological processes in a new light Genes Dev. 2003, 17, 545-580
6. Eigtved, A.; Andersson, A. P.; Dahlstrom, K.; Rabol, A.; Jensen, M.; Holm, S.; Sorensen, S. S.; Drzewiecki, K. T.; Hojgaard, L.; Friberg, L. Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of silent metastases from malignant melanoma Eur. J. Nucl. Med. 2000, 27, 70-75
7. Holder, W. D., Jr.; White, R. L., Jr.; Zuger, J. H.; Easton, E. J., Jr.; Greene, F. L. Effectiveness of positron emission tomography for the detection of melanoma metastases Ann Surg. 1998, 227, 764-769
8. discussion 769-771.
9. Schwimmer, J.; Essner, R.; Patel, A.; Jahan, S. A.; Shepherd, J. E.; Park, K.; Phelps, M. E.; Czernin, J.; Gambhir, S. S. A review of the literature for whole-body FDG PET in the management of patients with melanoma Q. J. Nucl. Med. 2000, 44, 153-167
10. Tyler, D. S.; Onaitis, M.; Kherani, A.; Hata, A.; Nicholson, E.; Keogan, M.; Fisher, S.; Coleman, E.; Seigler, H. F. Positron emission tomography scanning in malignant melanoma Cancer 2000, 89, 1019-1025
11. Beatovic, S.; Obradovic, V.; Latkovic, Z.; Jaksic, E. Diagnosis and follow up of primary ocular melanoma by radioimmunoscintigraphy J. BUON 2004, 9, 299-302
12. Voss, S. D.; Smith, S. V.; DiBartolo, N.; McIntosh, L. J.; Cyr, E. M.; Bonab, A. A.; Dearling, J. L.; Carter, E. A.; Fischman, A. J.; Treves, S. T.; Gillies, S. D.; Sargeson, A. M.; Huston, J. S.; Packard, A. B. Positron emission tomography (PET) imaging of neuroblastoma and melanoma with 64Cu-SarAr immunoconjugates Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 17489-17493
13. Kato, K.; Kubota, T.; Ikeda, M.; Tadokoro, M.; Abe, S.; Nakano, S.; Nishino, M.; Kobayashi, H.; Ishigaki, T. Low efficacy of 18F-FDG PET for detection of uveal malignant melanoma compared with 123I-IMP SPECT J. Nucl. Med. 2006, 47, 404-409
14. 64Cu-labeled α-melanocyte-stimulating hormone analog for microPET imaging of melanocortin 1 receptor expression Bioconjugate Chem. 2007, 18, 765-772
15. Cheng, Z.; Zhang, L.; Graves, E.; Xiong, Z.; Dandekar, M.; Chen, X.; Gambhir, S. S. Small-animal PET of melanocortin 1 receptor expression using a 18F-labeled alpha-melanocyte-stimulating hormone analog J. Nucl. Med. 2007, 48, 987-994
16. Miao, Y.; Benwell, K.; Quinn, T. P. 99mTc- and 111In-labeled alpha-melanocyte-stimulating hormone peptides as imaging probes for primary and pulmonary metastatic melanoma detection J. Nucl. Med. 2007, 48, 73-80
17. Ren, G.; Liu, Z.; Miao, Z.; Liu, H.; Subbarayan, M.; Chin, F. T.; Zhang, L.; Gambhir, S. S.; Cheng, Z. PET of malignant melanoma using 18F-labeled metallopeptides J. Nucl. Med. 2009, 50, 1865-1872
18. Ren, G.; Liu, S.; Liu, H.; Miao, Z.; Cheng, Z. Radiofluorinated rhenium cyclized alpha-MSH analogues for PET imaging of melanocortin receptor 1 Bioconjugate Chem. 2010, 21, 2355-2360
19. Larisch, R.; Schulte, K. W.; Vosberg, H.; Ruzicka, T.; Muller-Gartner, H. W. Differential accumulation of iodine-123-iodobenzamide in melanotic and amelanotic melanoma metastases in vivo J. Nucl. Med. 1998, 39, 996-1001
20. Chezal, J. M.; Papon, J.; Labarre, P.; Lartigue, C.; Galmier, M. J.; Decombat, C.; Chavignon, O.; Maublant, J.; Teulade, J. C.; Madelmont, J. C.; Moins, N. Evaluation of radiolabeled (hetero)aromatic analogues of N-(2-diethylaminoethyl)-4-iodobenzamide for imaging and targeted radionuclide therapy of melanoma J. Med. Chem. 2008, 51, 3133-3144
21. Pham, T. Q.; Berghofer, P.; Liu, X.; Greguric, I.; Dikic, B.; Ballantyne, P.; Mattner, F.; Nguyen, V.; Loc'h, C.; Katsifis, A. Preparation and biologic evaluation of a novel radioiodinated benzylpiperazine, 123I-MEL037, for malignant melanoma J. Nucl. Med. 2007, 48, 1348-1356
22. Eisenhut, M.; Hull, W. E.; Mohammed, A.; Mier, W.; Lay, D.; Just, W.; Gorgas, K.; Lehmann, W. D.; Haberkorn, U. Radioiodinated N-(2-diethylaminoethyl) benzamide derivatives with high melanoma uptake: structure-affinity relationships, metabolic fate, and intracellular localization J. Med. Chem. 2000, 43, 3913-3922
23. Michelot, J. M.; Moreau, M. F.; Veyre, A. J.; Bonafous, J. F.; Bacin, F. J.; Madelmont, J. C.; Bussiere, F.; Souteyrand, P. A.; Mauclaire, L. P.; Chossat, F. M. Phase II scintigraphic clinical trial of malignant melanoma and metastases with iodine-123-N-(2-diethylaminoethyl 4-iodobenzamide) J. Nucl. Med. 1993, 34, 1260-1266
24. Ren, G.; Miao, Z.; Liu, H.; Jiang, L.; Limpa-Amara, N.; Mahmood, A.; Gambhir, S. S.; Cheng, Z. Melanin-targeted preclinical PET imaging of melanoma metastasis J. Nucl. Med. 2009, 50, 1692-1699
25. Garg, S.; Kothari, K.; Thopate, S. R.; Doke, A. K.; Garg, P. K. Design, synthesis, and preliminary in vitro and in vivo evaluation of N-(2-diethylaminoethyl)-4-[18F]fluorobenzamide ([18F]-DAFBA): a novel potential PET probe to image melanoma tumors Bioconjugate Chem. 2009, 20, 583-590
26. Denoyer, D.; Labarre, P.; Papon, J.; Miot-Noirault, E.; Galmier, M. J.; Madelmont, J. C.; Chezal, J. M.; Moins, N. Development of a high-performance liquid chromatographic method for the determination of a new potent radioiodinated melanoma imaging and therapeutic agent J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2008, 875, 411-418
27. Greguric, I.; Taylor, S. R.; Denoyer, D.; Ballantyne, P.; Berghofer, P.; Roselt, P.; Pham, T. Q.; Mattner, F.; Bourdier, T.; Neels, O. C.; Dorow, D. S.; Loc'h, C.; Hicks, R. J.; Katsifis, A. Discovery of [18F]N-(2-(diethylamino) ethyl)-6-fluoronicotinamide: a melanoma positron emission tomography imaging radiotracer with high tumor to body contrast ratio and rapid renal clearance J. Med. Chem. 2009, 52, 5299-5302
28. Denoyer, D.; Greguric, I.; Roselt, P.; Neels, O. C.; Aide, N.; Taylor, S. R.; Katsifis, A.; Dorow, D. S.; Hicks, R. J. High-contrast PET of melanoma using (18)F-MEL050, a selective probe for melanin with predominantly renal clearance J. Nucl. Med. 2010, 51, 441-447
29. Allen-Auerbach, M.; Weber, W. A. Measuring response with FDG-PET: Methodological aspects Oncologist 2009, 14, 369-377
30. Al Jammaz, I.; Al-Otaibi, B.; Okarvi, S.; Amartey, J. Rapid and efficient synthesis of [F-18]fluoronicotinamides, [F-18]fluoroisonicotinamides, and [F-18]fluorobenzamides as potential PET radiopharmaceuticals for melanoma imaging J. Labelled Compd. Radiopharm. 2011, 54, 312-317
31. Cherng, Y. H. Synthesis of substituted pyridines by the reactions of halopyridines with sulfur, oxygen and carbon nucleophiles under focused microwave irradiation Tetrahedron 2002, 58, 4931-4935